Hypertyrosinaemia

Area of Science:

• Biochemistry
• Neonatal Medicine
• Pediatric Endocrinology

Background:

• Elevated blood tyrosine levels affect nearly 1% of newborns, presenting a significant neonatal health concern.
• Distinguishing between serious tyrosinosis and benign transient hypertyrosinemia is critical for appropriate management.

Purpose of the Study:

• To differentiate between classic tyrosinosis and benign hypertyrosinemia.
• To evaluate dietary treatment strategies for hypertyrosinemia.
• To assess the long-term psychomotor development in affected children.

Main Methods:

• Differential diagnostic methods involving ascorbic acid, pyridoxine, or folic acid loading.
• Dietary intervention using phenylalanine- and tyrosine-free hydrolysates.
• Psychomotor development assessment in untreated children.

Main Results:

• L-tyrosine tolerance tests were found to be ineffective for diagnosis.
• Dietary treatment with specialized hydrolysates showed positive results for both transitory and classic forms.
• Untreated children with hypertyrosinemia did not exhibit subnormal IQ until pre-school or school age.

Conclusions:

• Accurate differentiation of hypertyrosinemia forms is essential for timely and effective intervention.
• Dietary management plays a vital role in treating neonatal hypertyrosinemia.
• Delayed cognitive impairment highlights the importance of early diagnosis and treatment.